TY - JOUR
T1 - The impact of concordant and discordant conditions on the quality of care for hyperlipidemia
AU - Lagu, Tara
AU - Weiner, Mark G.
AU - Hollenbeak, Christopher S.
AU - Eachus, Susan
AU - Roberts, Craig S.
AU - Schwartz, J. Sanford
AU - Turner, Barbara J.
N1 - Funding Information:
Acknowledgements: Funding: Supported by Pfizer Inc. and the Robert Wood Johnson Foundation Clinical Scholars Program Conflicts of Interest: Funding for this project was provided by an unrestricted grant from Pfizer Inc. The University of Pennsylvania provided the mechanism for administration of this grant. Investigators at the University of Pennsylvania and Pennsylvania State University performed the analyses. By contract, the investigators retain the right to publish results and manuscripts without approval from Pfizer Inc. Dr. Lagu is funded by The Robert Wood Johnson Foundation Clinical Scholars Program.
PY - 2008/8
Y1 - 2008/8
N2 - BACKGROUND: Physician treatment of cardiovascular risk factors may be affected by specific types of patient comorbidities. OBJECTIVES: To examine the relationship between discordant comorbidities and LDL-cholesterol management in hypertensive patients not previously treated with lipid-lowering therapy; to determine whether the presence of cardiovascular (concordant) conditions mediates this relationship. DESIGN: We performed a retrospective cohort study of 1,935 hypertensive primary care patients (men >45 years of age, women >55 years of age) with documented elevated low-density lipoprotein (LDL) cholesterol and no lipid-lowering therapy at baseline. The outcome was guideline-consistent hyperlipidemia management defined as optimal value on repeat LDL cholesterol testing or initiation of lipid-lowering therapy. Using generalized estimating equations (GEE), we examined the association of concordant and discordant comorbidities with guideline-consistent hyperlipidemia management over a 2-year follow-up period, adjusting for patient characteristics. RESULTS: Guideline-consistent hyperlipidemia management was achieved in 1,236 patients (64%). In the fully adjusted model, each additional discordant condition resulted in a 19% lower adjusted odds ratio of guideline-consistent hyperlipidemia management (p<0.001) when compared with no discordant conditions. The dampening effect of discordant conditions on guideline-consistent management persisted even in the presence of concordant conditions, but each additional concordant condition was associated with a 37% increase in the adjusted odds of guideline-consistent hyperlipidemia management (p<0.001). CONCLUSIONS: In this cohort of hypertensive primary care patients, the number of conditions discordant with cardiovascular risk was strongly negatively associated with guideline-consistent hyperlipidemia management even in patients at the highest risk for cardiovascular events and cardiac death.
AB - BACKGROUND: Physician treatment of cardiovascular risk factors may be affected by specific types of patient comorbidities. OBJECTIVES: To examine the relationship between discordant comorbidities and LDL-cholesterol management in hypertensive patients not previously treated with lipid-lowering therapy; to determine whether the presence of cardiovascular (concordant) conditions mediates this relationship. DESIGN: We performed a retrospective cohort study of 1,935 hypertensive primary care patients (men >45 years of age, women >55 years of age) with documented elevated low-density lipoprotein (LDL) cholesterol and no lipid-lowering therapy at baseline. The outcome was guideline-consistent hyperlipidemia management defined as optimal value on repeat LDL cholesterol testing or initiation of lipid-lowering therapy. Using generalized estimating equations (GEE), we examined the association of concordant and discordant comorbidities with guideline-consistent hyperlipidemia management over a 2-year follow-up period, adjusting for patient characteristics. RESULTS: Guideline-consistent hyperlipidemia management was achieved in 1,236 patients (64%). In the fully adjusted model, each additional discordant condition resulted in a 19% lower adjusted odds ratio of guideline-consistent hyperlipidemia management (p<0.001) when compared with no discordant conditions. The dampening effect of discordant conditions on guideline-consistent management persisted even in the presence of concordant conditions, but each additional concordant condition was associated with a 37% increase in the adjusted odds of guideline-consistent hyperlipidemia management (p<0.001). CONCLUSIONS: In this cohort of hypertensive primary care patients, the number of conditions discordant with cardiovascular risk was strongly negatively associated with guideline-consistent hyperlipidemia management even in patients at the highest risk for cardiovascular events and cardiac death.
UR - http://www.scopus.com/inward/record.url?scp=49649106701&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=49649106701&partnerID=8YFLogxK
U2 - 10.1007/s11606-008-0647-4
DO - 10.1007/s11606-008-0647-4
M3 - Article
C2 - 18465174
AN - SCOPUS:49649106701
SN - 0884-8734
VL - 23
SP - 1208
EP - 1213
JO - Journal of general internal medicine
JF - Journal of general internal medicine
IS - 8
ER -